We’re excited to announce that on 30th October 2024, Joerns Healthcare’s UK business, including the ‘Oxford’ range of products, officially joined the Prism Healthcare Group. With a heritage dating back to the 1950s, Oxford is one of the leading brands in the patient handling and rehabilitation product markets.

The Oxford brand specialises in clinical hoisting equipment, slings and bathing equipment. The Prism Healthcare Group strategically adds the Oxford product ranges to its portfolio, reinforcing its dedication to transforming lives in home, long-term care, acute care, and paediatric settings. Additionally, Prism will take on board the full Oxford product set, including the ‘Professional’ and ‘Classic’ ranges as well as complementary bathing products, slings and other products supplied by Joerns UK. Within its core UK market, Joerns UK is a supplier to the community equipment market via loan store operators and independent local authorities, as well as to NHS Trusts, care homes and dealers.

Prism expects the acquisition of Joerns UK to strengthen its position. Subsequently, Prism is one of the UK’s leading providers of safe patient handling, pressure area care, and specialist seating equipment for individuals with limited mobility.

Chris Morgan, Managing Director of Joerns UK, will take on an expanded role within the enlarged Prism group. Furthermore, he will lead Prism’s UK Homecare and Acute Care businesses, including leading the Joerns UK team within the enlarged UK group.

Chris Morgan comments:

“I’m excited to join the Prism Healthcare Group in this new era and continue driving our company’s positive development. I’m passionate about working with the fantastic people in this industry and thrilled that the Prism group will support our ongoing success and growth. This will be for the shared benefit of our customers, our team and our supply chain partners.”

Jason Leek, CEO Prism Healthcare Group, adds:

“The Oxford range of products is an exciting addition to the Prism Healthcare Group. This acquisition strengthens our product offering, supports our expansion into the acute market and, most importantly, allows us to provide our customers a broader offer. I am very excited that we can expand the value-add offering for our customers as well as enhancing our relationships with our suppliers. I am delighted to welcome Chris Morgan and the Joerns team to the group and look forward to working together”.

Charme Capital Partners makes investment in Prism Healthcare, a leading UK provider of complex healthcare equipment and services, to support the Group’s further expansion in the UK and internationally.

London, 1 March 2022: Charme Capital Partners (“Charme”), the pan-European mid-market private equity firm, and Limerston Capital (“Limerston”) have announced that Charme IV has acquired Prism Healthcare (or “the Group”), a leading end-to-end provider of specialist healthcare equipment and services. As part of the transaction, Limerston will remain invested in the Group, providing long-term stability and support for Prism Healthcare’s continued development, while the management team will also retain a stake in the Group. Terms of the transaction were not disclosed.

Headquartered in Wakefield, Yorkshire, Prism Healthcare has a diverse portfolio of UK manufactured equipment, including safe patient handling, bathing, accessibility and pressure area care products. Its products provide healthcare professionals with affordable, clinically effective solutions to help disabled and mobility disadvantaged people remain mobile and active in their own homes, in long term care facilities or in acute care environments.

Prism Healthcare employs over 650 people and operates from nine UK locations, with a network of international distributors working across UK, EU and global markets. The Group’s customers include both public authorities and private providers, helping healthcare professionals provide excellent care, promote learning, aid movement or recovery, and support independence. Prism Healthcare develops, delivers, installs and services bespoke equipment that delivers vital improvements to the quality of life of its end users, with rapid response times enabled by its UK manufacturing footprint and nationwide team of engineers and assessors. The Group also has a strong product development pipeline, with a dedicated team continuously improving existing products and developing new ones to improve functionality for both users and carers.

Over the last three years, the business has doubled in size, successfully completing four add-on acquisitions, broadening its product range to become the most comprehensive in the country and expanding into new geographic areas to provide full UK coverage.

Charme’s investment will support the Group’s organic expansion through the continued development of its high-quality offering, to help more healthcare professionals provide the very best client care. Charme will also support the Group’s growth via acquisition, both in the UK and internationally.

Julian Huxtable, Partner at Charme Capital Partners, said: “We are delighted to be investing in Prism Healthcare and look forward to working closely with its management team to support the next phase of the Group’s expansion. Charme has proven expertise growing firms within the healthcare sector and, with local teams across Europe and extensive experience in internationalising businesses, we are well placed to help Prism Healthcare expand into new markets to bring its bespoke products and vital services to more customers.”

Paul Morton, CEO of Prism Healthcare, remarked: “We are thrilled to welcome Charme as a new investor in Prism Healthcare to support the Group’s continued development. We are confident that Charme is the right partner, with the right skills and experience, to help us realise our ambitious growth objectives. I would like to thank the team at Limerston Capital for their support in growing of the business over the past four years and I am delighted that they will remain an investor in the Group. We are excited to embark on a new chapter for Prism Healthcare, aimed at bringing our offering to more customers globally.”